-
公开(公告)号:WO0162233A3
公开(公告)日:2002-01-03
申请号:PCT/EP0101679
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , HUBER-TROTTMANN GERDA , KILPATRICK GAVIN JOHN , NORCROSS ROGER DAVID
IPC: A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
CPC classification number: C07D239/42 , A61K31/44 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , C07D213/85 , C07D231/12 , C07D233/56 , C07D239/47 , C07D239/48 , C07D239/56 , C07D249/08 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.
Abstract translation: 本发明涉及含有至少一个氮原子的环状杂芳族化合物,以及它们在制备用于治疗与腺苷受体调节剂诸如阿尔茨海默氏病,帕金森病,神经保护,精神分裂症,焦虑症等相关的疾病的药物中的用途, 疼痛,呼吸困难,抑郁症,哮喘,过敏反应,缺氧,局部缺血,癫痫发作,物质滥用,镇静作用,它们可能作为肌肉松弛剂,抗精神病药,抗癫痫药,抗惊厥药和心脏保护剂起作用。
-
公开(公告)号:WO0117999A3
公开(公告)日:2001-12-06
申请号:PCT/EP0008372
申请日:2000-08-28
Applicant: HOFFMANN LA ROCHE
Inventor: HUBER TROTTMANN GERDA , HUNKELER WALTER , JAKOB-ROETNE ROLAND , KILPATRICK GAVIN JOHN , NETTEKOVEN MATTHIAS HEINRICH , RIEMER CLAUS
IPC: C07D213/73 , A61K31/437 , A61K31/4418 , A61K31/444 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/635 , A61P9/10 , A61P11/06 , A61P11/16 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D409/04 , C07D471/04 , C07D519/00
CPC classification number: C07D471/04
Abstract: The invention relates to compounds of formula (I) wherein R is a 5 or 6 membered heteroaryl group, optionally substituted and optionally linked to the pyrazole ring via an alkylene or alkenyle group, or is phenyl, optionally substituted or is -O(CH2)nphenyl, benzofuryl, indolyl or benzothiophenyl, or is -S-lower alkyl; R and R are independently from each other hydrogen, cyano or -S(O)2-phenyl; R is hydrogen, halogen or is heteroaryl or phenyl, optionally substituted -NR'R" or -O-phenyl, or is -benzo[1,3]dioxolyl, -1H-indol-5-yl, naphthyl, benzofuran-2-yl, 1,3,4,9-tetrahydro-b-carbolin-2-yl, piperidin-1-yl, pyrrolidin-1-yl, piperazin-4-yl-methyl or morpholinyl; R is -NR2, n is 0-4 and their pharmaceutically acceptable salts. These compounds are adenosine receptor ligands.
Abstract translation: 本发明涉及式(I)化合物,其中R 1是5或6元杂芳基,任选被取代并任选地通过亚烷基或烯基连接到吡唑环上,或者是苯基,任选被取代或是-O (CH 2)n苯基,苯并呋喃基,吲哚基或苯并噻吩基,或是-S-低级烷基; R 2和R 4彼此独立地为氢,氰基或-S(O)2 - 苯基; R 3是氢,卤素或是杂芳基或苯基,任选取代的-NR'R“或-O-苯基,或是 - 苯并[1,3]二氧杂环戊烯基,-1H-吲哚-5-基,萘基,苯并呋喃 -2-基,1,3,4,9-四氢-b-咔啉-2-基,哌啶-1-基,吡咯烷-1-基,哌嗪-4-基 - 甲基或吗啉基; R 5是 -NR2,n为0-4及其药学上可接受的盐,这些化合物是腺苷受体配体。
-
3.
公开(公告)号:PL203805B1
公开(公告)日:2009-11-30
申请号:PL36514001
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , HUBER-TROTTMANN GERDA , KILPATRICK GAVIN JOHN , NORCROSS ROGER DAVID
IPC: C07D405/04 , A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
-
公开(公告)号:HRP20020673A2
公开(公告)日:2004-12-31
申请号:HRP20020673
申请日:2002-08-14
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , TROTTMANN GERDA HUBER , KILPATRICK GAVIN JOHN , NORCROSS ROGER DAVID
IPC: A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, anti epileptics, anticonvulsants and cardiaprotective agents.
-
公开(公告)号:YU13502A
公开(公告)日:2004-11-25
申请号:YUP13502
申请日:2000-08-28
Applicant: HOFFMANN LA ROCHE
Inventor: HUBER TROTTMANN GERDA , HUNKELER WALTER , JAKOB-ROETNE ROLAND , KILPATRICK GAVIN JOHN , NETTEKOVEN MATTHIAS HEINRICH , RIEMER CLAUS
IPC: C07D213/73 , A61K31/437 , A61K31/4418 , A61K31/444 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/635 , A61P9/10 , A61P11/06 , A61P11/16 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D409/04 , C07D471/04 , C07D519/00
Abstract: Pronalazak se odnosi na jedinjenja formule I, naznacena time sto R1 perdstavlja 5-to ili 6-toclanu heteroarilnu grupu, koja sadrzi 1 do 3 heteroatoma, izabrana izmedju N, O ili S, i cije su grupe opciono supstituisane jednim ili sa dva supstituenta, koji su nizi alkil, -(CH2)nOH, halogen ili nizi alkoksi, i naznacena time sto heteroarilne grupe mogu biti opciono vezane za pirazolski prsten preko nekog alkilena ili alkenil grupe ili je to fenil, opciono supstituisan jednim ili sa dva supstituenta, koji su nizi alkil, hidroksi-nizi alkil, halogen, hidroksi ili nizi alkoksi ili je -O(CH2)nfenil, benzofuril, indolil ili benzotiofenil ili je -S-nizi alkil; R2 i R4 su nezavisno jedan od drugog, vodonik, cijano ili -S(O)2-fenil; R3 je vodonik, halogen ili 5-to ili 6-toclana heteroarilna grupa, koja sadrzi 1 do 3 heteroatoma, izabrana izmedju N, O ili S i gde su grupe opciono supstituisane jednim ili sa dva supstituenta, koji su nizi alkil, -(CH2)n-aril, hldroksi, halogen, nizi alkoksi, morfolinil, amino, nizi alkilamino ili -C(O)NR'2, naznaceno time sto je R* nizi alkil ili vodonik ili je fenil, opciono supstituisan jednim ili sa dva supstituenta koji su halogen, nizi alkoksi, amino, di-nizi alkil amino, CF3, -OCF3, -NHC(O)nizi alkil cijano, -C(O)-nizi alkil, -C(O)O-nizi alkil, -S-nizi alkil, -S(O)2NH-fenil, -S(O)2metilpiperazinil; ili je NR'R", naznacen time sto su R' i R", nezavisno jedan od drugog, vodonik, -(CH2)nfenil, koji je opciono supstituisan halogenom ili nizom alkoksi grupom, -CH(nizi alkil)-fenil, indan-1-il, 1,2,3,4-tetrahidro-naftalen ili cikloalkil; ili je O-fenil, ciji je fenilni prsten opciono supstituisan halogenom, nizom alkil ili nizom alkoksi grupom, -O-tetraidronaftalenil ili -O-CH2-6-metil-piridin-2-il; ili je -benzol[1,3]dioksolil, -1H-indol-5-il, naftil, benzofuran-2-il, 1,3,4,9-tetrahidro-b-karbolin-2-il, piperidin-1-il, pirolidin-1-il, piperazin-4-il-metil ili morfolinil; R5 je -NR2, pri cemu R moze ili ne mora biti vodonik, nizi alkil, fenil, benzil, -CO-nizi alkil, -CO-nizi alkoksi, -nizi alkenil, -CO(CH2)n-fenil ili -COO(CH2)n-fenil, naznacen time sto je fenilni prsten opciono supstituisan sa CF3 nizom alkoksi, halogen ili nizom alkil grupom, -CO(CH2)3-NHCO-nizi alkoksi, -(CH2)n-fenil, naznacen time, sto je fenilni prsten opciono supstituisan nizom alkoksi, CF3 ili halogenom ili je 4,5-dihidro-1H-imidazol-2-il-benzojeva kiselina, 1,4,5,6-tetrahidro-pirimidin-2-il-benzojeva kiselina ili 4,5,6,7-tetrahidro-1H-[1,3]diazepin-2-il-benzojeva kiselina; n je 0-4, i njihove farmaceutski prihvatljive soli.
-
公开(公告)号:NO20021077D0
公开(公告)日:2002-03-05
申请号:NO20021077
申请日:2002-03-05
Applicant: HOFFMANN LA ROCHE
Inventor: TROTTMANN GERDA HUBER , HUNKELER WALTER , JAKOB-ROETNE ROLAND , KILPATRICK GAVIN JOHN , NETTEKOVEN MATTHIAS HEINRICH , RIEMER CLAUS
IPC: C07D213/73 , A61K31/437 , A61K31/4418 , A61K31/444 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/635 , A61P9/10 , A61P11/06 , A61P11/16 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D409/04 , C07D471/04 , C07D519/00 , C07D
Abstract: The invention relates to compounds of formulawhereinR1 is a 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, -(CH2)nOH, halogen or lower alkoxy, and wherein the heteroaryl groups may be optionally linked to the pyrazole ring via an alkylene or alkenyl group, or isphenyl, optionally substituted by one or two substituents being lower alkyl, hydroxy-lower alkyl, halogen, hydroxy or lower alkoxy or is-O(CH2)n,phenyl, benzofuryl, indolyl or benzothiophenyl, or is-S-lower alkyl;R2 and R4 are independently from each other hydrogen, cyano or -S(O)2-phenyl;R3 is hydrogen, halogen or isa 5 or 6 membered heteroaryl group, containing 1 to 3 heteroatoms, selected from N, O or S, and which groups are optionally substituted by one or two substituents, which are lower alkyl, -(CH2)n-aryl, hydroxy, halogen, lower alkoxy, morpholinyl, amino, lower alkylamino or -C(O)NR'2, and wherein R' is lower alkyl or hydrogen, or isphenyl, optionally substituted by one or two substituents being halogen, lower alkyl, lower alkoxy, amino, di-lower alkyl amino, CF3, -OCF3, -NHC(O)lower alkyl, cyano, -C(O)-lower alkyl, -C(O)O-lower alkyl, -S-lower alkyl, -S(O)2NH-phenyl, -S(O)2-methylpiperazinyl; or is-NR'R'', wherein R' and R'' are independently from each other hydrogen, -(CH2)nphenyl, which phenyl ring is optionally substituted by halogen or lower alkoxy, -CH(lower alkyl)-phenyl, indan-1-yl, 1,2,3,4-tetrahydro-naphthalen, or cycloalkyl; or is-O-phenyl, which phenyl ring is optionally substituted by halogen, lower alkyl or lower alkoxy, -O-tetrahydronaphthalenyl or -O-CH2-6-methyl-pyridin-2-yl; or is-benzo[1,3]dioxolyl, -1H-indol-5-yl, naphthyl, benzofuran-2-yl, 1,3,4,9-tetrahydro-b-carbolin-2-yl, piperidin-1-yl, pyrrolidin-1-yl, piperazin-4-yl-methyl or morpholinyl;R5 is -NR2, wherein R may be the same or different and is hydrogen, lower alkyl, phenyl, benzyl, -CO-lower alkyl, -CO-lower alkoxy, -lower alkenyl, -CO(CH2)n-phenyl or -COO(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by CF3, lower alkoxy, halogen or lower alkyl, -CO(CH2)3-NHCO-lower alkoxy, -(CH2)n-phenyl, wherein the phenyl ring is optionally substituted by lower alkoxy, CF3 or halogen, or is 4,5-dihydro-1H-imidazol-2-yl-benzoic acid, 1,4,5,6-tetrahydro-pyrimidin-2-yl-benzoic acid or 4,5,6,7-tetrahydro-1H-[1,3]diazepin-2-yl-benzoic acid;n is 0-4and their pharmaceutically acceptable salts
-
公开(公告)号:CA2398274A1
公开(公告)日:2001-08-30
申请号:CA2398274
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , NORCROSS ROGER DAVID , KILPATRICK GAVIN JOHN , HUBER-TROTTMANN GERDA
IPC: A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at leas t one nitrogen atom, and to their use in the manufacture of medicaments for th e treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be activ e as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.
-
公开(公告)号:CA2398274C
公开(公告)日:2009-09-22
申请号:CA2398274
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: NORCROSS ROGER DAVID , KILPATRICK GAVIN JOHN , HUBER-TROTTMANN GERDA , BORRONI EDILIO MAURIZIO
IPC: A61K31/506 , A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/465 , A61K31/4709 , A61K31/505 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at leas t one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be activ e as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.
-
公开(公告)号:AU780527B2
公开(公告)日:2005-03-24
申请号:AU5464301
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , HUBER-TROTTMANN GERDA , KILPATRICK GAVIN JOHN , NORCROSS ROGER DAVID
IPC: A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, anti epileptics, anticonvulsants and cardiaprotective agents.
-
公开(公告)号:PL365140A1
公开(公告)日:2004-12-27
申请号:PL36514001
申请日:2001-02-15
Applicant: HOFFMANN LA ROCHE
Inventor: BORRONI EDILIO MAURIZIO , HUBER-TROTTMANN GERDA , KILPATRICK GAVIN JOHN , NORCROSS ROGER DAVID
IPC: A61K31/00 , A61K31/44 , A61K31/4418 , A61K31/443 , A61K31/4436 , A61K31/444 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61P9/04 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/02 , A61P25/04 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P37/08 , A61P43/00 , C07D213/57 , C07D213/85 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/14 , C07D407/04 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D495/04 , C07D521/00
Abstract: The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, anti epileptics, anticonvulsants and cardiaprotective agents.
-
-
-
-
-
-
-
-
-